首页> 美国卫生研究院文献>Pilot and Feasibility Studies >A study protocol for a feasibility study: Propofol Target-Controlled Infusion in Emergency Department Sedation (ProTEDS)—a multi-centre feasibility study protocol
【2h】

A study protocol for a feasibility study: Propofol Target-Controlled Infusion in Emergency Department Sedation (ProTEDS)—a multi-centre feasibility study protocol

机译:可行性研究的研究方案:急诊室镇静中的异丙酚靶控输注(ProTEDS)—多中心可行性研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundProcedural sedation is a core skill of the emergency physician. Bolus administration of propofol is widely utilised in UK emergency departments to provide procedural sedation. Bolus administration of propofol, titrated to an endpoint of sedation, has a rapid effect but can easily result in apnoea and loss of airway patency. The use of a target-controlled infusion of propofol allows for controlled titration to an effect site concentration and may reduce the rate of adverse incidents. Target-controlled infusion of propofol is not currently used in emergency departments.The primary aim of this feasibility study is to ensure that propofol target-controlled infusion (TCI) is acceptable to the patient and that recruitment rates are adequate to power a randomised controlled trial comparing propofol target-controlled infusion versus bolus administration.
机译:背景技术镇静是急诊医师的一项核心技能。英国急诊部门广泛使用Bo​​lus丙泊酚管理来提供程序镇静作用。滴定至镇静终点的丙泊酚注射液具有快速作用,但很容易导致呼吸暂停和气道通畅性丧失。使用靶控输注的异丙酚可以控制滴定至有效部位的浓度,并可以减少不良事件的发生率。急诊室目前不使用丙泊酚靶控输注。该可行性研究的主要目的是确保患者可接受丙泊酚靶控输注(TCI),并且征募率足以支持随机对照试验比较异丙酚靶控输注与推注给药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号